-
Mashup Score: 2
CDK2 regulates the cell cycle and may have the potential to drive therapeutic resistance to common breast cancer drugs — including CDK4/6 inhibitors.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 1Investigators Look to Add Duvelisib to Treatment Arsenal of Rare T-Cell Lymphoma Subtype - 5 day(s) ago
Christopher P. Fox, PhD, discusses the upcoming phase 3 TERZO trial of duvelisib in patients with nodal T-cell lymphoma with follicular helper T phenotype.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Investigators Look to Add Duvelisib to Treatment Arsenal of Rare T-Cell Lymphoma Subtype @UniofNottingham #hematology #PTCL https://t.co/DQr50gh0Hp
-
-
Mashup Score: 2
Ritu Salani, MD, MBA, details the significance of trials examining avutometinib plus defactinib and enthusiasm for ADCs in ovarian cancer.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Avutometinib/Defactinib Combo Could Fill Sizeable Unmet Need in LGSOC @RSalaniMD @uclaobgynedu #gyncsm #oncology #MedEd https://t.co/ZszCrziQUC
-
-
Mashup Score: 1Certepetide Plus Gemcitabine and Nab-Paclitaxel Shows Preliminary Activity in Metastatic Pancreatic Cancer - 9 day(s) ago
Certepetide plus gemcitabine and nab-paclitaxel showed antitumor activity despite failing to improve PFS vs chemotherapy alone in untreated metastatic pancreatic cancer.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Certepetide plus gemcitabine and nab-paclitaxel showed antitumor activity despite failing to improve PFS vs chemotherapy alone in untreated metastatic pancreatic cancer. @ASCO #GI25 #pancsm #oncology https://t.co/jT8uQz2CiG
-
-
Mashup Score: 0Pelareorep Plus mFOLFIRINOX ± Atezolizumab Shows Acceptable Safety in Metastatic PDAC - 9 day(s) ago
Pelareorep plus modified FOLFIRINOX with or without atezolizumab showed acceptable safety in newly diagnosed metastatic pancreatic ductal adenocarcinoma.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Pelareorep combined with modified FOLFIRINOX with or without atezolizumab had acceptable safety with no new signals in patients with newly diagnosed metastatic pancreatic ductal adenocarcinoma. @ASCO #GI25 #pancsm #oncology https://t.co/vYk4pQZ1wh https://t.co/XkuI19xLP1
-
-
Mashup Score: 2
Intraperitoneal and intravenous paclitaxel plus S-1 improved OS over intravenous paclitaxel and S-1 alone in gastric cancer with peritoneal metastasis.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Intraperitoneal and intravenous paclitaxel plus S-1 improved OS over intravenous paclitaxel and S-1 alone in gastric cancer with peritoneal metastasis. @ASCO #GI25 #stcsm #oncology https://t.co/kcTFUZppj5
-
-
Mashup Score: 0
Surufatinib with TAS-102 produced promising survival outcomes and manageable toxicity as later-line therapy for a small cohort of patients with PDAC.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Surufatinib with TAS-102 produced promising survival outcomes and manageable toxicity as later-line therapy for a small cohort of patients with PDAC. @ASCO #GI25 #pancsm #oncology https://t.co/xmgxy2dqG3
-
-
Mashup Score: 1
First-line therapy with olaparib plus abiraterone demonstrated clinical benefit in rPFS and OS in mCRPC harboring germline and somatic BRCA mutations.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Olaparib Plus Abiraterone Improves Radiographic PFS and OS in BRCA+ mCRPC @ASCO @cancermtl #GU25 #pcsm https://t.co/QmtuKuNMCU
-
-
Mashup Score: 0Recapping the Latest in AML With Dr Eunice Wang - 9 day(s) ago
Eunice Wang, MD, of Roswell Park Comprehensive Cancer Center, sits down with Chandler Park, MD, FACP, to discuss the latest in acute myeloid leukemia from the 2024 ASH Annual Meeting.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Eunice Wang, MD, of @RoswellPark, sits down with Chandler Park, MD, FACP, to discuss the latest in acute myeloid leukemia from the 2024 ASH Annual Meeting. Watch more here: https://t.co/gt5yZOsJKQ
-
-
Mashup Score: 0OncLive - Clinical Oncology News, Cancer Expert Insights - 9 day(s) ago
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Today we share this week's #TestimonialTuesday! See what Dr Tawbi, of @MDAndersonNews, expert oncologist, had to say about #OncLive, and check back to our website to see timely updates from the oncology professionals themselves! #DoYouKnowOncLive https://t.co/LDL198hPGw https://t.co/tJebJaHtsE
-
Roswell Park-Led Team Proposes CDK2 Enzyme as New Target for Cancer Therapy @RoswellPark @ucsc #bcsm #oncology https://t.co/RozxOj5QDd